LYPLA2 Antibody (02) [DyLight 650]
Novus Biologicals, part of Bio-Techne | Catalog # NBP3-05819C
Conjugate
Catalog #
Key Product Details
Species Reactivity
Human
Applications
ELISA
Label
DyLight 650 (Excitation = 652 nm, Emission = 672 nm)
Antibody Source
Monoclonal Mouse IgG2B Clone # 02
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Product Specifications
Immunogen
This antibody was produced from a hybridoma resulting from the fusion of a mouse myeloma with B cells obtained from a mouse immunized with purified, recombinant Human LYPLA2 (Uniprot#: O95372; Met 1-Val 231).
Reactivity Notes
No cross-reactivity in ELISA with:
E.coli cell lysate
E.coli cell lysate
Specificity
No cross-reactivity in ELISA with: E.coli cell lysate
Clonality
Monoclonal
Host
Mouse
Isotype
IgG2B
Applications for LYPLA2 Antibody (02) [DyLight 650]
Application
Recommended Usage
ELISA
Optimal dilutions of this antibody should be experimentally determined.
Application Notes
Optimal dilution of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Protein A purified
Formulation
50mM Sodium Borate
Preservative
0.05% Sodium Azide
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C in the dark.
Background: LYPLA2
Long Name
Acyl-protein thioesterase 2
Alternate Names
APT-2, LPL-II, LysoPLA II
Gene Symbol
LYPLA2
Additional LYPLA2 Products
Product Documents for LYPLA2 Antibody (02) [DyLight 650]
Product Specific Notices for LYPLA2 Antibody (02) [DyLight 650]
DyLight (R) is a trademark of Thermo Fisher Scientific Inc. and its subsidiaries.
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...